The U.S. House subcommittee on energy and the environment on October 14 passed the American Medical Isotopes Production Act, sending the bill to the full Committee on Energy and Commerce for a vote.
HR 3276 would allocate $163 million to support projects for the production of molybdenum-99 without using highly enriched uranium in the process. The bill also prohibits export of highly enriched uranium from the U.S. for medical isotope production seven years after the bill becomes law.
The bill was amended by U.S. Rep. Edward Markey (D-MA), who also serves as subcommittee chairman, to stipulate that other medical isotopes, including iodine-131 and xenon-133, be produced as byproducts of the molybdenum-99 fission production process.
The bill designates the Secretary of Energy to determine which projects are worthy of funding. The criteria would be based on the time it would take for the applicant to begin molybdenum-99 production for medical uses, the ability to satisfy a significant percentage of U.S. demand for molybdenum-99, and the cost of the proposed project.
The bill also would require annual reports from the Department of Energy (DoE) for six years on the DoE's support of U.S. molybdenum-99 production.
AECL: Chalk River repair will cost $70M, October 20, 2009
SNM: Nuclear medicine tests being postponed, September 9, 2009
SNM draft report shows U.S. Mo-99 production years away, July 22, 2008
SNM explores feasibility of U.S. medical isotope source, May 22, 2008
Copyright © 2009 AuntMinnie.comIf you like this content, please share it with a colleague!